Holen Sie sich die Stockscreener-App
4.00
3.36%
0.13
Handel nachbörslich:
3.99
-0.010
-0.25%
Schlusskurs vom Vortag:
$3.87
Offen:
$3.9
24-Stunden-Volumen:
3.10M
Relative Volume:
0.63
Marktkapitalisierung:
$1.45B
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-4.9383
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
+0.50%
1M Leistung:
-7.41%
6M Leistung:
+44.40%
1J Leistung:
+124.72%
1-Tages-Spanne:
$3.795
$4.015
1-Wochen-Bereich:
$3.64
$4.19
52-Wochen-Spanne:
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
49 89 2153 9035
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Vergleichen Sie ATAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
4.00 | 1.41B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
AtaiBeckley: A Massive Market Opportunity But Execution Risk Exists (NASDAQ:ATAI) - Seeking Alpha
Atai Beckley N.V Financial Disclosures & Filings - TradingView — Track All Markets
AtaiBeckley completes redomiciliation from Netherlands to US - Proactive financial news
AtaiBeckley Completes Redomiciliation to the United States - The Manila Times
AtaiBeckley Inc. Completes Redomiciliation from Netherlands to Delaware, Streamlining Corporate Structure - Quiver Quantitative
Why a mental health drug maker just moved its legal home to Delaware - Stock Titan
Ataibeckley completes redomiciliation to the US - MSN
Net current asset value per share of Atai Beckley N.V – GETTEX:9VC - TradingView — Track All Markets
JonesTrading highlights differentiated pipeline at Atai Beckley NV (ATAI) - MSN
JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI) - Insider Monkey
Psychedelics stocks could benefit from marijuana rescheduling: Jefferies - MSN
13 Best Get Rich Fast Stocks to Buy Right Now - Insider Monkey
The 1 riskiest investment that paid off in 2025 - MSN
Atai Life Sciences (ATAI): Assessing an Expensive-Looking Valuation After a Strong Share Price Run - Yahoo Finance UK
Jones Trading Initiates Coverage of Atai Beckley N.V. (ATAI) with Buy Recommendation - Nasdaq
JonesTrading Initiates Coverage on ATAI Life Sciences With Buy Rating, $16 Price Target - marketscreener.com
Jones Trading initiates Buy rating on atai Life Sciences stock with $16 target - Investing.com
AtaiBeckley joins the Nasdaq Biotechnology Index - Proactive Investors
Atai Beckley Added to Nasdaq Biotechnology Index - marketscreener.com
Atai Beckley N.V. Added to NASDAQ Biotechnology Index, Marking a Significant Milestone for the Company - Quiver Quantitative
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - The Manila Times
Mental health drug developer joins key Nasdaq biotech index - Stock Titan
MarketBeat's Top 5 Rated Small-Cap Stocks - Finviz
Atai Beckley N.V.(NasdaqGM: ATAI) added to NASDAQ Biotechnology Index - marketscreener.com
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion - MSN
How Does Atai (ATAI)’s New EMP-01 Patent Shape Its Psychedelic Therapy Moat? - simplywall.st
Atai Life Sciences NV (ATAI) secures patent for social anxiety disorder formulation - MSN
Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation - Insider Monkey
CapEx per share of Atai Beckley N.V – LSX:A3CSB4 - TradingView — Track All Markets
New EMP-01 Patent Win Could Be A Game Changer For Atai Beckley (ATAI) - simplywall.st
ATAI Beckley Secures US Patent for EMP-01 to Treat Social Anxiety Disorder; Shares Up Pre-Bell - marketscreener.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - The Manila Times
AtaiBeckley (NASDAQ: ATAI) gains EMP-01 patent, eyes Phase 2a data in 2026 - Stock Titan
Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition By Investing.com - Investing.com South Africa
Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition - Investing.com Australia
ATAI Life Sciences Files Prospectus for Share Registration - TipRanks
Atai Beckley N.V. Files Prospectus Supplement for Common Shares - TradingView — Track All Markets
Atai Life Sciences (ATAI): Assessing an 8.8x Price-to-Book Valuation After a Volatile Share Price Run - Yahoo Finance
Atai Beckley (ATAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ATAIAtai Beckley N.V Short Interest - Finviz
ATAI Life Sciences Files Prospectus for Share Resale - MSN
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - ADVFN
Form 8-KCurrent report - ADVFN
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN
[Form 4] Atai Beckley N.V. Insider Trading Activity - Stock Titan
Atai Beckley N.V. (ATAI) latest stock news and headlines - Yahoo Finance UK
AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i - Proactive financial news
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):